Predictors of peripheral arterial disease in SLE change with patient's age

Jose-Gabriel Erdozain1, Irama Villar1, Javier Nieto1

  • 1Autoimmune Diseases Research Unit, Department of Internal Medicine , Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country , Bizkaia, The Basque Country , Spain.

Lupus Science & Medicine
|January 27, 2017
PubMed

Insights

Peripheral artery disease (PAD) risk factors differ by age in Systemic Lupus Erythematosus (SLE) patients. Younger SLE patients showed risks from antiphospholipid antibodies and glucocorticoids, while older patients had risks from hypertension and hypercholesterolemia.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Internal Medicine

Background:

  • Systemic Lupus Erythematosus (SLE) is an autoimmune disease associated with increased cardiovascular risk.
  • Peripheral Artery Disease (PAD) is a manifestation of systemic atherosclerosis and a marker of cardiovascular risk.
  • Understanding age-specific risk factors for PAD in SLE is crucial for targeted prevention and management.

Purpose of the Study:

  • To investigate how the influence of various risk factors for Peripheral Artery Disease (PAD) differs across age groups in patients diagnosed with Systemic Lupus Erythematosus (SLE).

Main Methods:

  • A cohort of 216 SLE patients was stratified into three age groups: ≤34 years, 35-49 years, and ≥50 years.
  • Peripheral Artery Disease (PAD) was diagnosed based on a low ankle-brachial index.
  • Univariant and multivariant analyses were employed to identify significant risk factors within each age group.

Main Results:

  • In patients ≤34 years, antiphospholipid antibodies/antiphospholipid syndrome and glucocorticoid use were significant risk factors for PAD.
  • In patients aged 35-49 years, hypertension was the sole statistically significant predictor of PAD, with a trend towards significance for fibrinogen levels.
  • In patients ≥50 years, hypercholesterolemia showed a trend towards being a risk factor for PAD.

Conclusions:

  • Age appears to be a significant modulator of the risk factors contributing to Peripheral Artery Disease (PAD) in patients with Systemic Lupus Erythematosus (SLE).
  • These findings highlight the need for age-stratified risk assessment and management strategies for PAD in SLE patients.
Abstract

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
519
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
566
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
519
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
300
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
298